Researchers make bipolar breakthrough

Oxford University researchers have discovered a possible new substitute for lithium in bipolar disorder treatment.

Experiments on mice have shown that ebselen can treat the condition without the toxicity and negative side effects of lithium. As the drug is known to be safe in humans, clinical trials can begin straight away.

Co-principal investigator Dr Grant Churchill of the Department of Pharmacology at Oxford University said: “Lithium has been used for over 60 years and remains the most effective treatment for bipolar disorder, but suffers from toxicity and has many side effects.”